We serve Chemical Name:2-amino-1-(4-methylpiperazin-1-yl)ethanone,dihydrochloride CAS:146788-11-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-amino-1-(4-methylpiperazin-1-yl)ethanone,dihydrochloride
CAS.NO:146788-11-6
Synonyms:2-Amino-1-(4-methylpiperazin-1-yl)ethanone dihydrochloride;Ethanone, 2-amino-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:2);2-Amino-1-(4-methyl-1-piperazinyl)ethanone dihydrochloride
Molecular Formula:C7H17Cl2N3O
Molecular Weight:230.135
HS Code:2933599090
Physical and Chemical Properties:
Melting point:274ºC
Boiling point:285.6ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:49.57000
Exact Mass:229.074875
LogP:0.89920
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Amino-1-(4-methylpiperazin-1-yl)ethanone dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-1-(4-methyl-1-piperazinyl)ethanone dihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-1-(4-methyl-1-piperazinyl)ethanone dihydrochloride Use and application,2-Amino-1-(4-methylpiperazin-1-yl)ethanone dihydrochloride technical grade,usp/ep/jp grade.
Related News: However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. (1S,2S,7R,9R)-10,12- dioxatricyclo[7.2.1.02,7]dodec-4-en-8-one manufacturers The Company most recently announced plans to establish a dedicated laboratory space with Biosafety Level-3 (BSL-3) containment to handle testing of SARS-CoV-2 (the viral strain causing COVID-19) and other similar pathogens that cause human disease. 1-hydroxy-3-[(5-nitrothiophen-2-yl)methylideneamino]urea suppliers AstraZeneca’s application for anifrolumab in SLE is under review by regulatory authorities in the US, EU and Japan, with decisions anticipated in the second half of 2021. Anifrolumab is not currently approved in any country. 7-hydroxy-5-pentadecyl-2-phenyl-chromen-4-one vendor & factory.
